Utah Medical Products stock, medical devices

Utah Medical Products stock reports a USD 75.00 tender offer

Published on 09/24/2026 at 22:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Utah Medical Products stock faces a 650,000-share tender deadline on October 7, 2026. Q2 sales fell 14.3 percent, while operating margin reached 31.1 percent.

Utah Medical Products stock,  medical devices,  self-tender offer,  Q2 2026 results,  Nasdaq, Illustration mit AI erstellt.
Utah Medical Products stock, medical devices, self-tender offer, Q2 2026 results, Nasdaq, Illustration mit AI erstellt.

Utah Medical Products stock stood at USD 74.75 on Nasdaq on September 24, 2026, down 0.35 percent from the previous close. The company is offering USD 75.00 per share for up to 650,000 shares, according to MarketScreener on September 15, 2026.

USD 75.00 tender offer

The issuer plans to repurchase up to 650,000 shares, representing 20 percent of its outstanding stock. The offer is scheduled to begin on September 22, 2026, and the tender deadline is October 7, 2026, unless the offer is extended.

The offer price is USD 0.25 above the September 24 market quote. The proposed repurchase also sits below the two-year intraday high of USD 75.75, while the current 52-week high is USD 76.89.

Q2 sales fall 14.3 percent

Utah Medical Products reported Q2 2026 revenue of USD 8.529 million, down 14.3 percent from Q2 2025, according to Stock Titan. Net income declined 11.9 percent to USD 2.686 million, while diluted EPS was USD 0.84.

Operating margin reached 31.1 percent in the quarter, despite the lower sales base. For the first half of 2026, revenue totaled USD 17.252 million, down 12.3 percent, and net income was USD 5.290 million, down 13.1 percent.

Stock remains near yearly high

The combination of a USD 75.00 tender price and a USD 74.75 market quote leaves only USD 0.25 between the offer and the latest Nasdaq price. The 52-week range extends from USD 53.66 to USD 76.89, placing the quote USD 2.14 below the yearly high.

Utah Medical Products had a market capitalization of USD 238.006 million on September 24, 2026. Its medical device portfolio serves hospital and outpatient applications, including labor and delivery, neonatal care, and women's health.

Utah Medical Products at a glance

  • Company: Utah Medical Products, Inc.
  • Ticker: UTMD
  • Trading venue: Nasdaq
  • Price: USD 74.75 on September 24, 2026
  • Market capitalization: USD 238.006 million as of September 24, 2026
  • 52-week range: USD 53.66-76.89
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

Disclaimer...

en | boerse | 70179496 |